Teva Ruling Creates Medicare Drug 'Chaos,' Full DC Circ. Told
The federal government asked the full D.C. Circuit on Friday to reconsider a panel ruling allowing Teva to challenge Medicare's rules for deciding which drugs qualify for price negotiations, arguing the...To view the full article, register now.
Already a subscriber? Click here to view full article